Currently, our commitments to clinical trial transparency apply to all interventional clinical trials conducted by LEO Pharma (including drug-device combination trials). Оur transparency framework meets, and in some cases exceeds, existing requirements from regulatory authorities and major industry associations regarding disclosure of clinical trial information.
All our clinical transparency activities carefully take the privacy of our trial participants into account, and we maintain their anonymity by protecting personal sensitive information using state-of-the art techniques.